Cargando…
A bioassay for cyclophosphamide in blood, lung and tumour.
A bioassay has been developed to detect and quantify the concentration of cytotoxic metabolites of cyclophosphamide (CY) in blood, tumour, and lungs of mice. Extracts were made of blood or solid tissues taken from mice given CY and these were used to treat log phase Chinese Hamster V79 cells in cult...
Autores principales: | Begg, A. C., Smith, K. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1984
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976679/ https://www.ncbi.nlm.nih.gov/pubmed/6691899 |
Ejemplares similares
-
T‐cell modulation by cyclophosphamide for tumour therapy
por: Hughes, Ellyn, et al.
Publicado: (2018) -
Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours.
por: Smith, K. A., et al.
Publicado: (1988) -
BioAssay Ontology (BAO): a semantic description of bioassays and high-throughput screening results
por: Visser, Ubbo, et al.
Publicado: (2011) -
Combined effect of buthionine sulfoximine and cyclophosphamide upon murine tumours and bone marrow.
por: Ono, K., et al.
Publicado: (1986) -
Circulating immunoreactive and bioassayable opsonic plasma fibronectin during experimental tumour growth
por: Saba, T. M., et al.
Publicado: (1980)